Nucleolar casein kinase 2 alpha as a prognostic factor in patients with surgically resected early‑stage lung adenocarcinoma.

MLA

Muto, Satoshi, et al. “Nucleolar Casein Kinase 2 Alpha as a Prognostic Factor in Patients with Surgically Resected Early‑stage Lung Adenocarcinoma.” Oncology Reports, vol. 53, no. 1, Jan. 2025. EBSCOhost, https://doi.org/10.3892/or.2024.8837.

APA

Muto, S., Homma, M. K., Kiko, Y., Ozaki, Y., Watanabe, M., Okabe, N., Hamada, K., Hashimoto, Y., & Suzuki, H. (2025). Nucleolar casein kinase 2 alpha as a prognostic factor in patients with surgically resected early‑stage lung adenocarcinoma. Oncology Reports, 53(1). https://doi.org/10.3892/or.2024.8837

Chicago

Muto, Satoshi, Miwako Kato Homma, Yuichiro Kiko, Yuki Ozaki, Masayuki Watanabe, Naoyuki Okabe, Kazuyuki Hamada, Yuko Hashimoto, and Hiroyuki Suzuki. 2025. “Nucleolar Casein Kinase 2 Alpha as a Prognostic Factor in Patients with Surgically Resected Early‑stage Lung Adenocarcinoma.” Oncology Reports 53 (1). doi:10.3892/or.2024.8837.